ESC 365 - Cisplatin therapy as a risk factor for incident atrial fibrillation

ESC Premium Access

Cisplatin therapy as a risk factor for incident atrial fibrillation

Session: Cancer and the heart: novel insights from bench to bedside

Topic: Cardio-Oncology

Speaker: Doctor B. Chalazan (Vancouver, CA)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Brandon Chalazan

University of British Columbia, Vancouver (Canada)

0 follower

3 more presentations in this session

Cardiac surveillance during breast cancer treatment; a snapshot of current practice.

Speaker: Miss Y. Koop (Utrecht, NL)

Predictors of progression of preclinical left ventricular diastolic dysfunction to clinical heart failure in patients with malignancy

Speaker: Doctor S. Javed (The Bronx, US)

Anti-tumor activity of a nanoliposomal anti-PCSK9 vaccine in BALB/c mice bearing 4T1 breast cancer.

Speaker: Professor M. Banach (Lodz, PL)

Access the full session

Cancer and the heart: novel insights from bench to bedside

Speakers: Doctor B. Chalazan, Miss Y. Koop, Doctor S. Javed, Professor M. Banach

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by